Skylight Health Group Stock Price To Sales
| SLHGFDelisted Stock | USD 0.21 0.00 0.00% |
Skylight Health Group fundamentals help investors to digest information that contributes to Skylight Health's financial success or failures. It also enables traders to predict the movement of Skylight Pink Sheet. The fundamental analysis module provides a way to measure Skylight Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Skylight Health pink sheet.
Skylight |
Skylight Health Group Company Price To Sales Analysis
Skylight Health's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Skylight Health Price To Sales | 0.23 X |
Most of Skylight Health's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Skylight Health Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
CompetitionBased on the latest financial disclosure, Skylight Health Group has a Price To Sales of 0.2293 times. This is 98.93% lower than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The price to sales for all United States stocks is 97.99% higher than that of the company.
Skylight Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Skylight Health's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Skylight Health could also be used in its relative valuation, which is a method of valuing Skylight Health by comparing valuation metrics of similar companies.Skylight Health is currently under evaluation in price to sales category among its peers.
Skylight Fundamentals
| Return On Equity | -0.97 | ||||
| Return On Asset | -0.24 | ||||
| Profit Margin | (0.38) % | ||||
| Operating Margin | (0.48) % | ||||
| Current Valuation | 37.31 M | ||||
| Shares Outstanding | 39.82 M | ||||
| Shares Owned By Insiders | 11.07 % | ||||
| Shares Owned By Institutions | 12.68 % | ||||
| Number Of Shares Shorted | 91.22 K | ||||
| Price To Book | 0.80 X | ||||
| Price To Sales | 0.23 X | ||||
| Revenue | 27.16 M | ||||
| Gross Profit | 15.09 M | ||||
| EBITDA | (16.57 M) | ||||
| Net Income | (13.75 M) | ||||
| Cash And Equivalents | 2.25 M | ||||
| Cash Per Share | 0.06 X | ||||
| Total Debt | 31.74 M | ||||
| Debt To Equity | 1.17 % | ||||
| Current Ratio | 1.21 X | ||||
| Book Value Per Share | 0.31 X | ||||
| Cash Flow From Operations | (11.31 M) | ||||
| Short Ratio | 2.93 X | ||||
| Number Of Employees | 259 | ||||
| Beta | 2.26 | ||||
| Market Capitalization | 8.32 M | ||||
| Total Asset | 65.45 M | ||||
| Net Asset | 65.45 M |
About Skylight Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Skylight Health Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Skylight Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Skylight Health Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Skylight Pink Sheet
If you are still planning to invest in Skylight Health Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Skylight Health's history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |